NextGen Health
Finnrick has tested 3 samples from NextGen Health across 1 product.
Finnrick Vendor Profile
NextGen Health
Tracking 1 product
3 total samples tested
Last test 4 Nov 2025
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Tirzepatide | 3 | 11 Jun 2025 | 4 Nov 2025 | |||||
The NextGen Health samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent NextGen Health tests
Samples are tested in commercial labs
3
tests
1
products
Scores
AVGMINMAX
First
11 Jun 2025
Last
4 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Nov 2025 | Tirzepatide | View | 10mg | 9.95mg | -0.5% | 99.68% | NG Peptide/Tirz/050625 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 29 Jun 2025 | Tirzepatide | View | 30mg | 27.3mg | -9.0% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 11 Jun 2025 | Tirzepatide | View | 20mg | 19.2mg | -4.0% | 99.81% | (no batch ID) | No Label / Silver Crimp / Grey Cap | Lab E | Public | |